Image courtesy of Anthony Quintano.

Early hopes around a treatment can change once stronger evidence appears. Sometimes benefits are smaller than first believed. Other times the real value is different than expected.

New research suggests Paxlovid may not lower hospitalization or death rates in certain vaccinated high-risk adults. However, it may still help people recover faster. The findings came from two randomized controlled trials, considered a strong form of medical evidence. Researchers studied people who had received COVID-19 vaccines and were still considered at higher risk for complications.

What Are the Findings?

The trials took place in the United Kingdom and Canada. Together, they included more than 4,000 participants. Most had been vaccinated against COVID-19. Every participant had symptoms for fewer than five days when treatment began. That timing matters because antivirals often work best early in infection.

Participants were randomly assigned into two groups. One group received standard medical care plus Paxlovid. The other group received standard care alone. This design helps researchers compare outcomes fairly and reduce bias.

Patients in the studies were considered high-risk for several reasons. Many were over age 50. Others were younger adults with health conditions linked to worse COVID-19 outcomes. These included illnesses such as Asthma and Diabetes.

The results showed little difference in the most serious outcomes. In one trial, the reduction in hospitalization or death was only 0.1 percent. In the other, the difference was 0.6 percent in favor of Paxlovid. Those numbers suggest the drug did not meaningfully reduce those risks in this specific vaccinated high-risk group.

Yet the medicine still showed possible benefits. In a subgroup of 634 participants, Paxlovid lowered viral load, meaning less virus was detected in the body. That may help explain why recovery improved.

Researchers found Paxlovid increased the odds of early sustained recovery by 36 percent in one trial and 31 percent in the other. In practical terms, some people taking the drug got better sooner and stayed better. For people eager to shorten illness and return to normal life, that may still be meaningful.

Many participants also reported side effects, which is important when weighing treatment choices. Like many medicines, benefits must be balanced against drawbacks.

These findings help clarify Paxlovid’s role in the current stage of the pandemic. For vaccinated high-risk adults, the drug may not strongly cut hospitalization or death risk. But it may still shorten illness, reduce viral burden, and ease recovery. That makes it less of a miracle cure and more of a targeted tool.

Conclusion

Paxlovid did not meaningfully lower hospitalization or death rates in vaccinated high-risk adults in two new trials. It did appear to lower viral load and help some people recover faster. The findings suggest Paxlovid may be more useful for shortening illness than preventing severe outcomes in this group.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

While the COVID-19 pandemic has been declared over, the effects of COVID-19 are still felt across the United States. Fortunately, recent research reinforces the effectiveness of COVID-19 vaccines, showing that the 2025–2026 vaccine reduced emergency room and urgent care visits by 50% and hospitalizations by 55%.

While the virus continues to mutate, this research is crucial. It shows that updated vaccines can still provide meaningful protection against severe illness.

What Were the Covid-19 Vaccine Findings?

The research, published in JAMA Network Open, analyzed nearly 90,000 visits to emergency rooms and urgent care centers. Additionally, researchers reviewed more than 26,000 hospitalizations. These cases included adults aged 18 and older who had symptoms similar to COVID-19.

The study did not include immunocompromised participants. This helped researchers create a clearer baseline for measuring vaccine effectiveness among the general adult population.

To get a comprehensive national view, researchers used a U.S. Centers for Disease Control and Prevention network spanning seven states. This network included more than 250 emergency departments and urgent care centers, as well as nearly 180 hospitals.

While this data aligns with previous research showing vaccine effectiveness, these recent findings also came under scrutiny. The findings were originally slated for CDC publication in April but were later rejected for methodological reasons.

However, the research used a test-negative design, a common method for evaluating vaccine effectiveness. In this approach, researchers include patients who sought medical care for similar symptoms. Then, they compare which patients tested positive for COVID-19 and which had been vaccinated.

This method can help researchers estimate how well vaccines prevent medically attended illness. In this case, the results showed strong protection against both emergency care and hospitalization.

Why Are COVID-19 Vaccines So Important?

Though COVID-19 continues mutating and spreading, a possible summer spike seems to have largely been averted. During summer months, many people spend more time indoors near air conditioning units. As a result, recent years have shown jumps in cases during July and August.

However, COVID-19 caseloads remain substantial. The study estimated around 400,000 to 550,000 infections in the United States between late 2024 and late 2025. In these cases, around 40% of hospitalizations occurred among patients aged 65 and older.

The study also corroborated findings from other recent research published in JAMA Network Open. In that study, COVID-19 vaccination prevented infections severe enough to require medical care by nearly 60% among older adults who had been vaccinated one to two months earlier.

Still, both studies showed low COVID-19 vaccine uptake. In the CDC-linked study, only 11% of patients had received a 2025–2026 booster. In the other study, just 6% of individuals infected with COVID-19 had been vaccinated.

Together, these figures show the continued need for improved trust and higher vaccination rates. While COVID-19 vaccines remain effective, they can only help those who choose to receive them.

For many patients, especially older adults, updated vaccination remains one of the clearest ways to reduce the risk of severe COVID-19.

Conclusion

Recent research shows COVID-19 vaccines still prevent severe illness. Updated boosters reduced emergency visits and hospitalizations among adults. Older adults especially benefit, but vaccination rates remain worryingly low.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Entering the hotter months of the year, the risk of tick-borne disease transmission increases significantly. As the climate warms, researchers warn that these threats may continue to worsen. For this reason, experts encourage anyone spending time outdoors to understand common tick-borne illnesses and how to prevent them.

Ticks can spread diseases, including Lyme disease, Rocky Mountain spotted fever, ehrlichiosis, babesiosis, anaplasmosis, and alpha-gal syndrome. Researchers are currently developing a vaccine to help prevent Lyme disease, but it is not yet available to the public. Current plans for the vaccine would require three initial doses followed by annual boosters. As a result, experts say preventive measures will remain important even if a vaccine becomes widely available.

Why Are Tick-Related Illnesses Rising?

Ticks thrive in warm, humid environments. Mild winters and hotter summers allow ticks to remain active for longer periods each year. Climate change is also helping some tick populations expand northward into regions that were previously too cold for them to survive. At the same time, growing deer and mouse populations provide ticks with more opportunities to feed and reproduce. White-footed mice are particularly important hosts for ticks that spread Lyme disease.

Lyme disease is the most commonly reported tick-borne illness in the United States. It is spread by black-legged ticks, also known as deer ticks, that carry the bacteria Borrelia burgdorferi or Borrelia mayonii. These ticks are most common in the Northeast, Mid-Atlantic, and Upper Midwest regions.

Common symptoms of Lyme disease include fever, headache, fatigue, and muscle aches. About 70% of patients develop a rash, often described as a bullseye pattern. However, Lyme disease rashes can appear in several different forms. Without treatment, the infection may spread and affect the joints, nervous system, and heart. Fortunately, most cases can be successfully treated with antibiotics.

Another growing concern is alpha-gal syndrome (AGS). This condition is most commonly associated with bites from lone star ticks, although other tick species may also contribute. Alpha-gal is a sugar molecule found in many mammals but not in humans. After a tick bite, some individuals develop an immune response to alpha-gal. As a result, eating red meat or other mammal-derived products can trigger allergic reactions hours after consumption.

Cases of alpha-gal syndrome have increased in recent years. Because there is currently no cure, management typically involves avoiding foods and products that contain alpha-gal, including certain red meats and, in some cases, dairy products.

Rocky Mountain spotted fever, ehrlichiosis, babesiosis, and anaplasmosis remain additional tick-borne illnesses of concern. These diseases can cause symptoms ranging from fever and fatigue to severe complications if left untreated.

Preventing Tick Bites and Infections

The Centers for Disease Control and Prevention (CDC) recommends several steps to reduce the risk of tick bites. Avoid walking through tall grass, dense brush, and heavily wooded areas whenever possible. When spending time in tick-prone environments, treat clothing and gear with 0.5% permethrin. In addition, use EPA-registered insect repellents on exposed skin.

After returning indoors, carefully inspect clothing and skin for ticks. Clothing worn outside should be placed in a dryer on high heat for at least 10 minutes to kill any ticks that may still be attached. Pet owners should also examine their animals for ticks after spending time outdoors.

Taking a shower soon after outdoor activities may help reduce the risk of Lyme disease. During tick checks, pay close attention to the armpits, behind the ears, along the hairline, inside the belly button, behind the knees, and other hard-to-see areas of the body.

As temperatures rise, emergency room visits related to tick-borne diseases are occurring earlier in the year and more frequently than in previous decades. If a tick is discovered, it should be removed promptly. In general, the longer a tick remains attached, the greater the chance it may transmit disease-causing organisms.

If a tick bite occurs, consider taking a photograph of both the tick and the bite site. This information may help healthcare providers identify the species involved and assess potential disease risks. Most importantly, monitor your health closely after any tick bite. If unusual symptoms develop, contact a healthcare provider as soon as possible.

Conclusion

Tick-borne illnesses are rising as warmer seasons lengthen tick activity. Lyme disease and alpha-gal syndrome remain growing outdoor risks. Prevention depends on repellents, treated clothing, and careful inspection.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Antibiotic resistance is one of humanity’s oldest ongoing biological battles. This struggle began long before humans created modern antibiotic medicines. Today, bacteria are gaining ground while antibiotics steadily lose effectiveness worldwide. Now, one out of six bacterial infections shows some resistance. Antibiotic-resistant bacteria cause more than four million deaths each year.

Human antibiotic use increases the speed of resistance development in bacteria. However, this battle is also unfolding in an unexpected place: the soil. Soil ecosystems have hosted antibiotic competition for thousands of years.

Researchers studied how environmental changes might influence antibiotic resistance patterns. They discovered that drought conditions can increase resistance in soil bacteria. This finding suggests soil resistance may contribute to human bacterial infections.

How is Soil Linked to Resistance?

As soil becomes drier, antibiotic compounds become more concentrated within it. Normally, water dilutes antibiotics, reducing their strength and overall impact. When soil dries, bacteria face stronger and more frequent antibiotic exposure. This repeated exposure pushes bacteria to develop stronger resistance over time..

To test this theory, researchers collected soil samples from multiple regions. Samples came from the United States, China, and Europe across diverse environments. These locations helped represent global patterns in soil and climate conditions.

The results showed that drier soils contain more antibiotic resistance genes. In many cases, these were also antibiotic-producing genes within soil bacteria. Gene presence increased as drought conditions lasted longer in each region. When bacteria produce antibiotics, weaker strains often die off quickly. The remaining bacteria are those already resistant to these powerful compounds.

Researchers reexamined soil samples and confirmed higher resistance in drier environments. They also created controlled experiments using artificial soil ecosystems for testing. In these experiments, scientists added antibiotics directly into the artificial soil. When the soil dried, antibiotic concentrations increased significantly within the system. Non-resistant bacterial strains were nearly eliminated under these drought conditions.

Antibiotic-producing bacteria survived because they resist their own chemical defenses. This survival pattern mirrors what researchers observed in natural soil environments. The findings suggest drought creates ideal conditions for resistant bacteria to dominate.

However, how soil resistance affects human infections remains an open question. Scientists are still investigating how resistance genes move into human pathogens.

Some evidence suggests a connection between soil bacteria and hospital infections. Researchers found similar resistance genes in both soil and hospital bacteria samples. In one case, a resistance gene matched perfectly between both environments. This finding suggests possible transfer pathways, though the exact mechanism remains unclear. Injuries involving soil exposure may allow bacteria to enter human systems.

Researchers also tested other factors linked to antibiotic resistance worldwide. Lower-income regions often show higher resistance due to limited healthcare resources. Poor sanitation and reduced infection control contribute to faster bacterial spread. However, even in high-income regions, drought still correlated with resistance levels. This indicates environmental dryness plays an independent role in resistance development.

The hospital data used in this research covered 116 countries worldwide. This broad dataset strengthens the link between environment and resistance patterns.

Overall, the findings reveal a hidden environmental driver of antibiotic resistance. Drought conditions may quietly shape bacterial evolution on a global scale. Understanding this process could help guide future strategies to fight resistant infections.

Conclusion

Drought can make soil antibiotics stronger, helping resistant bacteria survive. These resistant bacteria may share genes with human infections worldwide. Understanding this link could help slow rising antibiotic resistance globally.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of NIAID.

In the First Boer War, Dutch Boers studied British weaknesses carefully. British troops wore bright uniforms and used weak battlefield formations. These flaws made them easy targets for skilled Boer fighters. Boer farmers developed ambush tactics that surprised British forces. These strategies helped them win the First Boer War.

Long conflicts often force both sides to adapt and evolve. A similar battle exists between viruses and bacteria over time. They have fought each other for millions of years. Each side develops defenses and countermeasures to survive attacks. This conflict stores valuable genetic information inside bacterial genomes.

Researchers studied this genetic data to find antiviral defense systems. They created databases that catalog thousands of protective bacterial proteins. These discoveries may help create powerful new therapies for humans.

How Were New Antivirals Found?

Both research teams used machine learning to study bacterial genomes. They designed algorithms to identify proteins that fight viral infections. These tools scanned large datasets to detect hidden defense systems. The models predicted hundreds of thousands of possible antiviral proteins.

These findings build on earlier discoveries in bacterial defense systems. Scientists previously found CRISPR-Cas9 gene editing tools in bacteria. They also discovered restriction enzymes that cut harmful DNA strands. Researchers later adapted these systems into powerful genetic technologies.

The new studies aim to find similar tools for future applications. However, bacterial defense proteins are difficult to detect and study. Past research identified more than 250 antiviral proteins in bacteria. Still, scientists suspected many more defenses remained undiscovered.

In one study, researchers used deep learning to analyze genes. They trained models using protein and gene sequence data. The results showed about 1.5 percent of genes provide antiviral defense. This rate is three times higher than earlier scientific estimates.

Researchers then tested findings in two bacterial species directly. They studied Escherichia coli and Streptomyces albus in experiments. Scientists identified 12 antiviral systems that block viral attacks. These systems defend against bacteriophages, viruses that infect bacteria.

Previously, scientists did not know these systems fought viruses. This discovery expands understanding of bacterial immune defense systems.

The research also produced a new tool called Defense Predictor. This tool analyzes 17,000 bacterial genomes for antiviral proteins. It predicts which proteins may provide immunity against viruses.

Scientists tested Defense Predictor on 69 strains of E. coli. The tool identified 624 potential antiviral proteins in total. More than 100 of these proteins were previously unknown. Researchers tested these proteins in 42 experimental trials.

Results showed many proteins successfully activated antiviral defenses. These findings confirm the tool’s ability to detect real systems.

Researchers also created a database called Defense Finder. This database includes over 44,000 predicted antiviral systems. It allows scientists to explore bacterial defenses more easily.

What’s Next?

Both tools are free and available for public scientific use. Future research can test these predicted systems in real experiments. Scientists may discover entirely new ways to fight viral infections.

Studying bacterial defenses could lead to new antiviral drugs. It may also inspire new molecular tools for genetic research. Researchers hope these findings reveal how bacteria evolved immunity.

The ongoing battle between bacteria and viruses continues to inform science. By studying this conflict, scientists uncover tools for human health.

Conclusion

Bacteria and viruses have battled for millions of years, shaping powerful defenses. Scientists used machine learning to find many new bacterial antiviral proteins. These discoveries could lead to new drugs and advanced genetic technologies.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Today, infectious diseases remain the leading source of preventable death around the world. Compounding this problem, reliable diagnostics are often difficult to access. Current methods can take time, and they cannot always detect diseases early enough for the best treatment outcomes.

Recently, researchers explored whether metabolomics could help identify infections sooner. Metabolomics is the study of small molecules called metabolites. These molecules can serve as biomarkers, showing signs of infection within the body.

To evaluate how well metabolomics works for disease detection, researchers conducted a systematic review and meta-analysis. Their review covered studies published from 2014 to 2025. Across these studies, researchers examined whether metabolomics biomarkers could accurately identify bacterial, viral, and parasitic infections.

In their findings, researchers showed that metabolomics biomarkers were reliable diagnostic aids. In particular, they showed promise in detecting diseases during early stages of infection. Accordingly, researchers suggest that metabolomics could become an additional tool alongside more traditional diagnostic methods.

Why Is Metabolomics a Promising Detection Tool?

In metabolomics, small molecule metabolites are carefully analyzed. These metabolites result from gene expression, cellular activity, and other biological processes. Unlike genomics and proteomics, metabolomics can show changes as they happen in real time.

As a result, metabolomics may be especially useful for identifying early infections. For instance, metabolic processes involving amino acids, lipids, and immune system activity can all be detected. These changes may provide important clues before symptoms become severe or harder to treat.

Previous research has shown the usefulness of metabolomics for diagnosis. However, there has been broad methodological inconsistency across studies. For this reason, the systematic review and meta-analysis helped researchers get a firmer grasp on its usefulness.

Because the studies examined bacteria, viruses, and parasites, the review offered a broad look at infectious diseases. Overall, researchers found that metabolomics biomarkers showed strong diagnostic capabilities across the 22 studies included in the analysis.

One interesting finding was that bacterial infections showed slightly greater diagnostic accuracy. Researchers propose that bacteria may cause unique changes in amino acids and other metabolic processes. These changes may be easier to detect through metabolomics.

Still, researchers note that more research is needed to understand this trend. Additional studies may also help explain why viral infections were slightly less predictable. Importantly, researchers tested for publication bias and found that their results were unlikely to be overstated.

What’s Next for Metabolomics in Disease Detection?

Beyond diagnosis alone, metabolomics could also help tailor patient care. By giving clinicians a clearer live snapshot of a patient’s metabolic profile, metabolomics may eventually support more personalized treatment decisions.

Still, researchers acknowledge important limitations. Most of the included studies were observational, which means some bias may remain. Differences in study procedures may also affect results.

Finally, many of the included studies had fairly small sample sizes. Future research should investigate unique disease profiles more rigorously. With further study, metabolomics may become a valuable tool for detecting infections earlier and guiding more effective care.

Conclusion

Metabolomics may help detect infections earlier than traditional diagnostic tools. Researchers found strong biomarker accuracy across many infectious disease studies. Further research could improve clinical use and personalized patient care.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Mikael Häggström, M.D..

For years, natural medicine and modern science have been framed as opposing forces. Many people are told to choose one side or the other. Yet research shows that some traditional remedies may hold real medical value when studied. A new example comes from turmeric and ginger, two plants used in cooking and healing traditions.

Researchers at Washington State University found that extracts from turmeric and ginger may improve bone implants. These findings suggest that ancient knowledge and modern engineering can sometimes work together.

What Were the Findings?

Bone implants are medical devices placed into damaged areas of the skeleton. They are often used after fractures, joint damage, or severe wear from age. Common examples include hip replacements and titanium supports used after injury. These implants can restore movement and reduce pain. However, they do not always succeed.

One major problem is poor bonding between the implant and the body. If the surrounding bone does not attach well, the implant may loosen or fail over time. Another serious issue is infection. Bacteria can grow on implant surfaces and create stubborn colonies that resist treatment. In many cases, infected implants must be removed and replaced. This process can be painful, expensive, and physically difficult for patients.

The research team tested a coating made from turmeric and ginger extracts on titanium implants. They designed the coating to slowly release useful compounds over time. This allowed the implant surface to interact with surrounding tissue in a more supportive way.

The results were striking. Within six weeks, coated implants bonded to bone at nearly twice the normal rate. This means the body accepted and integrated the implants far better than untreated versions. Stronger bonding may reduce loosening and increase long-term success.

The coating also showed strong antibacterial effects. It removed more than 90 percent of bacteria on the implant surface. This is important because infection remains one of the leading causes of implant failure. A safer implant surface could help many future patients avoid revision surgeries.

Researchers also studied osteosarcoma-related cells. Osteosarcoma is a dangerous bone cancer that often affects children, teens, and younger adults. Treatment can involve surgery and chemotherapy, yet complete removal is not always possible. In the study, the turmeric and ginger coating reduced cancer-related cells around the implant area. The effect showed eleven times fewer cancerous cells compared with untreated samples.

What’s Next?

Turmeric and ginger have been used for thousands of years in regions such as India and China. Traditional healers valued them for inflammation, digestion, and general wellness. Modern research has already shown that compounds in both plants can have anti-inflammatory and antioxidant effects. This new study adds another possible benefit.

The findings do not mean eating turmeric or ginger will repair a broken implant or cure cancer. Instead, they show how plant compounds may be transformed into targeted medical tools. Scientists still need human trials and further testing before widespread use.

Even so, the study offers a hopeful reminder. Sometimes wisdom from the past can help solve problems of the present. When traditional knowledge is tested through science, surprising breakthroughs may emerge.

Conclusion

Researchers found turmeric and ginger coatings helped bone implants bond and fight infection. The treatment also sharply reduced cancer-related bone cells in early testing. The study shows some traditional plant compounds may improve future medical implants.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Sometimes important answers appear in unexpected and surprising places. People often find lost items hidden under cushions or inside drawers. Researchers discovered a similar surprise while studying vitamin D and COVID-19.

Scientists found regular vitamin D intake may reduce Long COVID risk. This finding came from researchers at Mass General Brigham. Their results were published in the Journal of Nutrition.

How Did Research Find the Link?

Earlier studies explored vitamin D because it supports immune system function. However, past research linking vitamin D and COVID-19 showed unclear results. Researchers designed this study to better understand that relationship.

They created the VIVID trial to study vitamin D and COVID-19. The study included adults recently diagnosed with COVID-19 and their families. Participants came from both the United States and Mongolia.

A total of 1,747 adult participants were included in the analysis. Additionally, 277 family members joined the study under separate conditions. These family members received either vitamin D3 supplements or a placebo daily.

Participants took supplements or a placebo for a period of four weeks. Most participants began supplementation about three days after testing positive.

The United States trial ran from December 2020 through September 2022. The Mongolia portion ran from September 2021 through April 2022.

Researchers used randomization to reduce bias across the study groups. They also adjusted for factors that could influence results. These included age, sex, body mass index, race, and ethnicity. Vaccination status was also considered as a possible influencing factor.

The study found no meaningful change in COVID-19 symptom severity. It also showed no reduction in the likelihood of virus transmission.

However, researchers noticed a possible connection to Long COVID outcomes. Participants taking vitamin D showed a slightly lower risk of symptoms.

These long-term symptoms were measured eight weeks after initial infection. Participants taking supplements had a 21 percent chance of symptoms. Those taking a placebo had a 25 percent chance of symptoms.

This represents a 4 percent reduction in Long COVID risk. The difference was considered barely statistically significant by researchers.

What’s Next?

Even so, the findings remain important for future investigation efforts. Long COVID can cause wide-ranging and serious long-term health effects.

Because of this, even small improvements may have meaningful impacts. Researchers believe this signal could guide future clinical studies.

Further research will help confirm whether vitamin D truly reduces risk. Scientists will need larger studies and stronger statistical evidence. For now, the findings offer a cautious but promising direction forward.

Conclusion

Vitamin D supplements did not reduce COVID-19 severity or spread. However, participants showed a small decrease in Long COVID risk. Researchers say more studies are needed to confirm these early findings.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

Each year, travelers face a changing landscape of health risks. In 2026, global travel, migration, and environmental changes continue to create new opportunities for infectious diseases to spread. Mosquito-borne illnesses are increasing in many regions. Meanwhile, vaccine-preventable diseases, once controlled, are returning in some parts of the world. Understanding these risks is essential for anyone preparing international travel plans.

Among the most significant concerns is dengue fever. Annually, up to 400 million people are infected with dengue worldwide. Of those infected, approximately one-quarter develop symptoms. Cases continue to rise across many regions. Dengue remains one of the most common mosquito-borne illnesses affecting travelers today.

What You Should Know about Dengue

Historically, dengue has been concentrated in Southeast Asia, South Asia, the Pacific Islands, Latin America, the Caribbean, and parts of Africa. But the virus is no longer confined to these traditional hotspots. Climate change, urbanization, and increasing international travel have expanded the range of mosquitoes capable of transmitting dengue. Researchers estimate that by 2100, as many as 8.4 billion people could face exposure to mosquito-borne diseases such as dengue and malaria.

The World Health Organization continues to classify dengue as a Grade 3 emergency. This designation is its highest level of emergency response. Today, dengue transmission occurs across approximately 110 countries. It affects nearly half of the world’s population.

Dengue is caused by a virus spread primarily through the bite of infected Aedes aegypti mosquitoes. Increasingly, Aedes albopictus, commonly known as the Asian tiger mosquito, is also contributing to transmission. Malaria-transmitting mosquitoes are often associated with nighttime exposure. However, dengue-carrying mosquitoes commonly bite during daylight hours.

The disease usually causes symptoms four to seven days after infection. Common signs include fever, headache, muscle pain, joint pain, nausea, and rash. Most people recover without complications. However, some infections become severe and can lead to dengue hemorrhagic fever. This is a potentially life-threatening condition involving bleeding, shock, and organ damage.

Because there is no specific treatment that cures dengue, prevention remains the most effective defense. Travelers should wear long sleeves and long pants whenever practical, use EPA-approved insect repellents, and stay in accommodations with screened windows, air conditioning, or mosquito nets.

It is also important to understand where dengue mosquitoes thrive. Unlike many people assume, Aedes mosquitoes are highly adapted to urban environments. They often breed in small collections of standing water around homes, hotels, and businesses. Even a bottle-cap-sized amount of stagnant water can provide a suitable breeding site. Travelers should avoid areas with standing water whenever possible, particularly during rainy seasons when mosquito populations tend to increase.

Other Travel Risks in 2026

While dengue receives significant attention, similar trends are affecting other mosquito-borne illnesses. Malaria, Zika virus, and West Nile virus continue to pose health concerns in many parts of the world. Although malaria is also spread by mosquitoes, it differs from dengue because it is caused by a protozoan parasite rather than a virus.

The geographic range of mosquito-borne diseases is also expanding. While dengue remains most common in tropical and subtropical regions, transmission is increasingly reported in areas of the Americas, including Puerto Rico, Hawaii, and parts of Florida. Some European countries are also experiencing growing numbers of locally acquired cases.

At the same time, vaccine-preventable diseases are creating additional concerns for travelers. Measles outbreaks have increased across portions of North America and Europe in recent years. Because measles is highly contagious, airports, train stations, cruise terminals, and other transportation hubs can become areas of elevated transmission risk.

Many travelers mistakenly assume childhood vaccinations provide lifelong protection without reviewing their immunization records. Before traveling, individuals should confirm that recommended vaccinations are current and discuss destination-specific vaccine requirements with a healthcare provider.

Polio presents another example of a disease many consider a historical threat. While global vaccination efforts dramatically reduced transmission, outbreaks continue to occur in some regions due to gaps in immunization coverage and international travel.

As travel patterns evolve, so do infectious disease risks. Taking preventive measures, staying current on vaccinations, and understanding local health conditions can help travelers reduce their risk and enjoy safer journeys in 2026.

Conclusion

Mosquito-borne diseases like dengue are spreading as climate change, travel, and urbanization expand mosquito habitats. Meanwhile, lower vaccination rates and unequal access are fueling outbreaks of measles and polio. Travelers can reduce risk by staying vaccinated and avoiding mosquito bites.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.

Image courtesy of Pexels.

In surprising findings, recent research has linked vaccines to lower dementia risk. Another recent study may help explain why this connection exists. Researchers found that severe infections may increase dementia risk years later. The findings suggest that preventing infections could help protect brain health.

The study included more than 62,000 older adults. Researchers recruited participants in 2016 and followed them through 2021. Participants were at least 65 years old when the study began. The average participant age was approximately 81 years old.

What Are the Findings?

Researchers compared participants diagnosed with dementia against a large control group. Nearly 313,000 control participants did not develop dementia during the same period. After analyzing the data, researchers identified 29 medical conditions associated with later dementia diagnosis. These conditions were diagnosed between one and 21 years before dementia appeared.

Importantly, the results remained significant even after accounting for other illnesses. Researchers found that dementia was much more common among participants with these conditions. The conditions covered a broad range of health problems. These included injuries, mental disorders, cardiovascular disease, neurological conditions, and endocrine disorders.

Among all participants, 47 percent experienced at least one linked condition. More than 20 percent developed two associated conditions. Some of the most common conditions included ischemic stroke, traumatic brain injury, and type 2 diabetes. However, not every condition carried the same level of risk.

Mental disorders showed some of the strongest associations with dementia. Researchers believe this may result from physical brain damage or other neurological changes. Parkinson’s disease and alcohol-related mental disorders also demonstrated particularly strong connections. Depending on the condition, diagnoses typically occurred five to 12 years before dementia developed.

Researchers also examined severe infections requiring hospital treatment. More than 65 percent of the studied diseases showed links to increased infection risk. Urinary tract infections, or UTIs, appeared especially important. Strong associations were found between UTI risk and conditions such as epilepsy, hemorrhagic stroke, and alcohol-related disorders.

What’s Next?

Scientists proposed several explanations for the connection between infections and dementia. One possibility involves inflammation triggered by severe infections. Other theories include immune system communication problems and harmful substances circulating in the blood. Researchers suggest these processes may gradually affect the brain over time.

Importantly, the findings do not suggest that infections directly cause dementia in most cases. Instead, severe infections may help create conditions that allow dementia to develop. Researchers describe this process as contributing to preclinical dementia. In other words, the disease process may begin long before symptoms appear.

To strengthen their findings, researchers analyzed participants by sex and education level. The associations remained consistent across these groups. However, the team acknowledged limitations. Some lifestyle behaviors and other factors could not be fully measured.

Dementia is typically diagnosed after age 80. Many older adults also have medical conditions that increase infection risk. Researchers believe their findings highlight the importance of preventing and treating serious infections. While the results are compelling, further studies are needed to determine whether prevention, treatment, or both offer the greatest protection against dementia.

Conclusion

Researchers found that severe infections may increase dementia risk years later. The findings suggest that infection-related inflammation could help create conditions that allow dementia to develop. More research is needed, but preventing and treating serious infections may help protect long-term brain health.

Have an upcoming trip? Passport Health offers a wide variety of options to help keep you safe from disease, including vaccines. Call or book online to schedule your appointment today.

Logan Hamilton is a health and wellness freelance writer for hire. He’s passionate about crafting crystal-clear, captivating, and credible content that elevates brands and establishes trust. When not writing, Logan can be found hiking, sticking his nose in bizarre books, or playing drums in a local rock band. Find him at loganjameshamilton.com.